About this trial
Hyperandrogenism is a common reason for consultation, the causes of which can range from common conditions (PCOS) to rarer conditions with major genetic implications (NC21OHD). It is characterized by elevated levels of circulating androgens, mainly testosterone. This excess of androgens usually manifests clinically as increased male-pattern hair growth and, less specifically, acne and alopecia. Its prevalence is estimated at between 6 and 12% in women of reproductive age, and its incidence is increasing.
It is also responsible for infertility. As a reminder, infertility is a major public health issue and affects more and more couples around the world.
The investigators therefore wish to develop innovative tools to improve the diagnosis and management of hyperandrogenism
Eligibility criteria
Qualifiers
Patients of childbearing age (16 to 45 years old)
Suffering from hyperandrogenism
Established etiological diagnosis with elimination of differential diagnoses
Informed and not opposed to the collection of their data for the purposes of the study
Disqualifiers
Pregnancy
Patients under legal protection measures
Trial design
Treatments tested in this trial
- data collection